(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 4.06% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.87%.
Innospec's revenue in 2024 is $1,948,800,000.On average, 2 Wall Street analysts forecast IOSP's revenue for 2024 to be $50,432,281,692, with the lowest IOSP revenue forecast at $49,139,146,264, and the highest IOSP revenue forecast at $51,725,417,120.
In 2025, IOSP is forecast to generate $52,682,834,697 in revenue, with the lowest revenue forecast at $50,855,037,505 and the highest revenue forecast at $54,510,631,888.